Fig. 2From: Understanding the socioeconomic costs of dystrophic epidermolysis bullosa in Europe: a costing and health-related quality of life studyOverall mean annual cost per dystrophic epidermolysis bullosa patient broken down by type of cost (2020, €)Back to article page